Cognate BioServices a Charles River company

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics and Vigene Biosciences, join Charles River to offer customers a single,...

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics and Vigene Biosciences, join Charles River to offer customers a single, trusted partner. We have supported the development of 15 FDA-approved cell and gene therapies and have conducted more than 1,000 studies in this field over the past year

• Belgium
• 12016754332

Visit Website Linkedin